Results 171 to 180 of about 42,507 (225)

Pembrolizumab-Induced Aplastic Anemia Successfully Treated With Thrombopoietin Receptor Agonist in a Patient With Lung Adenocarcinoma: A Case Report and Literature Review. [PDF]

Cureus
Namba K, Isobe K, Nakao S, Hiruta N, Wakabayashi H.   +4 more
europepmc   +1 more source

Aplastic anemia following high-voltage electrical injury: A case report. [PDF]

Trauma Case Rep
Ayaz M, Ayaz D, Keshavarz A.
europepmc   +1 more source

Osimertinib-induced aplastic anemia after curative surgery for <i>EGFR</i>-mutant lung adenocarcinoma. [PDF]

Respir Med Case Rep
Kawamura T, Minagi K, Kawabata S, Suzuki H.   +3 more
europepmc   +1 more source

A De Novo Splicing Mutation of SRP72 in Bone Marrow Failure Syndrome Type 1: Case Report and Review of the Literature. [PDF]

Mol Genet Genomic Med
Xiangwen W, Duo Z, Wenjing H, Hui H.
europepmc   +1 more source

NGS identifies novel HLA-DQA1 and DPB1 associations with aplastic anemia in the Kazakhstani population. [PDF]

Front Immunol
Turganbekova A, Zhanzakova Z, Kanabekova P, Baimukasheva D, Saduakas Z, Khamitova D, Abdrakhmanova S, Masalimov Z, Almawi WY.   +8 more
europepmc   +1 more source

Successful Treatment of Posttransplant Refractory Pure Red Cell Aplasia Following Parvovirus B19 Infection. [PDF]

Case Rep Med
Ansara Y, Marouf O, Abualhumos K, AbuBaha M, Salameh H, Saadeddin H, Al-Sheikh M.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Aplastic anemia: Pathophysiology

Seminars in Hematology, 2022
Bone marrow failure (BMF) syndromes are a heterogeneous group of benign hematological conditions characterized by uni- or multi-lineage marrow and/or peripheral blood cytopenia(s), and can be classified in constitutional or acquired syndromes based on pathophysiology.
Giudice V., Selleri C.
openaire   +3 more sources